These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 22538522)
61. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy. Amano K Intern Med; 2006; 45(17):991-2. PubMed ID: 17015997 [No Abstract] [Full Text] [Related]
62. Clinical trials. Gene transfer an unlikely contributor to patient's death. Kaiser J Science; 2007 Dec; 318(5856):1535. PubMed ID: 18063761 [No Abstract] [Full Text] [Related]
67. Efficiency of potentiated antibodies to tumor necrosis factor-alpha (Artrofoon) in the therapy of patients with rheumatoid arthritis. Petrov VI; Babaeva AR; Cherevkova EV; Epstein OI; Sergeeva SA Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():155-8. PubMed ID: 12949686 [TBL] [Abstract][Full Text] [Related]
68. The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy. Tarnowski M; Paradowska-Gorycka A; Dąbrowska-Zamojcin E; Czerewaty M; Słuczanowska-Głąbowska S; Pawlik A Expert Opin Drug Metab Toxicol; 2016; 12(1):41-55. PubMed ID: 26609565 [TBL] [Abstract][Full Text] [Related]
70. Fulminant course of osteonecrosis of the jaw in a rheumatoid arthritis patient following oral bisphosphonate intake and biologic therapy. Ebker T; Rech J; von Wilmowsky C; Neukam FW; Stockmann P Rheumatology (Oxford); 2013 Jan; 52(1):218-20. PubMed ID: 23238981 [No Abstract] [Full Text] [Related]
71. [Influence of tumor necrosis alpha blockade with infliximab on lipid profile in patients with active rheumatoid arthritis]. Pérez-Galán MJ; Salvatierra-Ossorio J; Cáliz-Cáliz R; Guzmán-Ubeda MA Med Clin (Barc); 2006 May; 126(19):757. PubMed ID: 16759594 [No Abstract] [Full Text] [Related]
73. Comments on the original article by Soubrier et al. "Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis". Seriolo B; Paoliono S; Ferrone C; Cutolo M Joint Bone Spine; 2009 Jan; 76(1):117-8; author reply 118. PubMed ID: 19084458 [No Abstract] [Full Text] [Related]
74. The effects of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis. Payet S; Pereira B; Soubrier M; Mathieu S Semin Arthritis Rheum; 2012 Feb; 41(4):e4-5; author reply e6. PubMed ID: 22154222 [No Abstract] [Full Text] [Related]
75. Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002). Furst DE; Breedveld FC; Kalden JR; Smolen JS; Antoni CE; Bijlsma JW; Burmester GR; Cronstein B; Keystone EC; Kavanaugh A; Klareskog L Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii2-7. PubMed ID: 12379612 [No Abstract] [Full Text] [Related]
76. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006. Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Emery P; Keystone EC; Schiff MH; van Riel PL; Weinblatt ME; Weisman MH Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii2-15. PubMed ID: 17038465 [No Abstract] [Full Text] [Related]
77. [Optimized treatment of a patient having rheumatoid arthritis and gout at the same time]. Nordström D; Leirisalo-Repo M; Petterson T Duodecim; 2013; 129(10):1045-8. PubMed ID: 23767136 [TBL] [Abstract][Full Text] [Related]
78. Herpes zoster in the age of focused immunosuppressive therapy. Whitley RJ; Gnann JW JAMA; 2009 Feb; 301(7):774-5. PubMed ID: 19224757 [No Abstract] [Full Text] [Related]
79. Cigarette smoking, TB, and TNF inhibitors. Bieber J; Kavanaugh A Ann Rheum Dis; 2003 Nov; 62(11):1118-9. PubMed ID: 14583580 [No Abstract] [Full Text] [Related]
80. New and promising treatments for rheumatoid arthritis. Looney RJ; Stohl W Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):18-23. PubMed ID: 17694190 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]